Clinical Trials Sponsored by Intas Pharmaceuticals, Ltd.

Total 4443 results

Peking University
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.; Beijing Biostar Pharmaceuticals...

Recruiting

Utidelone and Anlotinib in Advanced Recurrent Metastatic Esophageal Cancer

Esophageal Cancer

China
Kissei Pharmaceutical Co., Ltd.
Maruishi Pharmaceutical

Completed

A Clinical Study of MR13A9 in Hemodialysis Patients With Pruritus.

Uremic Pruritus

Japan
Glenmark Pharmaceuticals Ltd. India
Glenmark Pharmaceuticals S.A.

Completed

GRC 27864 First in Man, Single Ascending Dose Study in Healthy Volunteers

Healthy

United Kingdom
Glenmark Pharmaceuticals Ltd. India
Glenmark Pharmaceuticals S.A.

Completed

A Clinical Trial to Study the Effects GRC 17536 in Patients With Painful Diabetic Peripheral Neuropathy (Painful Extremities Due to Peripheral Nerve Damage in Diabetic Patients).

Painful Diabetic Peripheral Neuropathy

India, Czech Republic, Germany, United Kingdom
Glenmark Pharmaceuticals Ltd. India
Glenmark Pharmaceuticals S.A.

Completed

A Clinical Trial to Study the Effects of Revamilast in Patients With Chronic Persistent Asthma

Asthma

Poland, Czech Republic, India, Russian Federation, United Kingdom
Glenmark Pharmaceuticals Ltd. India
Glenmark Pharmaceuticals S.A.

Completed

Safety and Tolerability of GBR 900 in a Single Ascending Dose Study in Healthy Subjects

Healthy

United Kingdom
Glenmark Pharmaceuticals Ltd. India
Glenmark Pharmaceuticals S.A.

Completed

A Clinical Trial to Study the Effects of Revamilast in Patients With Rheumatoid Arthritis (TERRA)

Rheumatoid Arthritis

Philippines, India, Poland, Sri Lanka, United Kingdom
Glenmark Pharmaceuticals Ltd. India
Glenmark Pharmaceuticals S.A.

Withdrawn

A Clinical Trial to Study the Effects of GRC 17536 in Patients With Painful Diabetic Neuropathy (Painful Extremities Due to Peripheral Nerve Damage in Diabetic Patients)

Painful Diabetic Neuropathy

Germany, United Kingdom
Douglas Pharmaceuticals America Ltd
Novum Pharmaceutical Research Services; ACM Global Laboratories

Completed

A Therapeutic Equivalence Study of Ketoconazole Cream 2%

Tinea Pedis

Belize, United States
Tianjin Hemay Pharmaceutical Co., Ltd
Hainan General Sanyang Pharmaceutical Co., Ltd

Terminated

Study Evaluating Hemay020 In Subjects With Advanced Solid Cancer

Neoplasms，Non-Small Cell Lung Cancer

China
Tianjin Hemay Pharmaceutical Co., Ltd

Recruiting

A Phase Ⅲ Study of Hemay022 in Combination With AI In Advanced Breast Cancer

Breast Cancer

China
Tianjin Hemay Pharmaceutical Co., Ltd

Completed

Multiple Ascending Dose Study to Assess Safety and Pharmacokinetics of Hemay005 In Healthy Subjects (Hemay005)

Psoriasis

China
Tianjin Hemay Pharmaceutical Co., Ltd

Completed

A Phase Ⅱ Study of Hemay808 for Atopic Dermatitis Patients

Atopic Dermatitis

China
Tianjin Hemay Pharmaceutical Co., Ltd

Completed

Study Evaluating Hemay022 In Subjects With HER2-Positive Advanced Breast Cancer

HER2 Positive Breast Cancer

China
Haisco Pharmaceutical Group Co., Ltd.
Haisco Pharmaceutical(Australia) Pty Ltd.

Completed

A Study of Safety, Tolerability, and Pharmacokinetics of Single Ascending Dosed of HSK31858 in Healthy Volunteers

Healthy

Australia
Tianjin Hemay Pharmaceutical Co., Ltd

Terminated

A Study to Evaluate the Efficacy and Safety of Hemay005 in the Treatment of Behçet Disease

Behçet Disease

China
Xizang Haisco Pharmaceutical Co., Ltd

Recruiting

A Study for HSK39775 in Participants With Solid Tumors

Advanced Solid Tumors

China
Xizang Haisco Pharmaceutical Co., Ltd

Not yet recruiting

A Study of HSK21542 in a Peritoneal Dialysis Pruritus Population.

Pruritus
Tianjin Hemay Pharmaceutical Co., Ltd

Completed

Study Evaluating Hemay022 in Combination With Endocrine Therapy In Subjects With ER Positive and HER2 Positive Advanced Breast Cancer

Breast Cancer

China
Tianjin Hemay Pharmaceutical Co., Ltd

Terminated

Phase II Study of Hemay007 in Patients With Active Ulcerative Colitis

Ulcerative Colitis

China
Tianjin Hemay Pharmaceutical Co., Ltd

Completed

A Phase Ⅲ Efficacy and Safety Study of Hemay005 in Subjects With Moderate to Severe Plaque Psoriasis

Psoriasis

China
Tianjin Hemay Pharmaceutical Co., Ltd

Completed

A Phase I Clinical Study of Hemay808

Safety Issues

China
Tianjin Hemay Pharmaceutical Co., Ltd

Completed

A Phase 2 Study of Hemay007 in Patients With Rheumatoid Arthritis

Rheumatoid Arthritis

China
Xizang Haisco Pharmaceutical Co., Ltd

Active, not recruiting

Pharmacokinetics, Mass Balance, and Metabolism of [14C]HSK31679 in Healthy Adult Male Volunteers.

Healthy

China
Tianjin Hemay Pharmaceutical Co., Ltd

Completed

Phase II Study of Hemay005 in Patients With Active Ankylosing Spondylitis

Active Ankylosing Spondylitis

China
Tianjin Hemay Pharmaceutical Co., Ltd

Completed

Efficacy and Safety Study of Hemay005 in Subjects With Moderate to Severe Plaque Psoriasis

Psoriasis

China
Shandong Luye Pharmaceutical Co., Ltd.
Nanjing Sike Pharmaceutical Co., Ltd.

Completed

Pharmacokinetics Study of Liposomal Paclitaxel in Humans (LPS-PK-H)

Cancer

China
Daewoong Pharmaceutical Co. LTD.

Not yet recruiting

to Evaluate the Safety/Tolerability and Pharmacokinetics, and Pharmacodynamics of DWP14012 Injection

Erosive Gastroesophageal Reflux Disease
Daewoong Pharmaceutical Co. LTD.

Not yet recruiting

Registry Study to Determine the Effectiveness and Safety of Weight Loss With Enavogliflozin in Patients With Type 2 Diabetes Mellitus

Type 2 Diabetes Mellitus
SamA Pharmaceutical Co., Ltd

Recruiting

The Efficacy and Safety of Atock Dry Syrup With Acute Bronchitis Patients

Acute Bronchitis

Korea, Republic of
BioRay Pharmaceutical Co., Ltd.

Not yet recruiting

A Phase I Study of BR115 for Injection Alone in Subjects With Advanced Solid Malignancies

Advanced Solid Malignancies

China
Boryung Pharmaceutical Co., Ltd

Recruiting

A Study to Evaluate the Efficacy and Safety of Fixed-Dose Combination of Pitavastatin/Ezetimib

Mixed Dyslipidemia | Primary Hypercholesterolemia

Korea, Republic of
Ono Pharmaceutical Co. Ltd

Recruiting

A Study to Investigate the Efficacy and Safety of ONO-4578 in Combination With Nivolumab and Chemotherapy in Chemotherapy-naïve Participants With HER2-negative Unresectable Advanced or Recurrent Gastric Cancer (Including Esophagogastric Junction Cancer)

Gastric Cancer

Korea, Republic of, Taiwan, Japan
Qilu Pharmaceutical Co., Ltd.

Recruiting

A Study Comparing Pharmacokinetic and Safety of QL2107 and Keytruda® (Marketed in China and the United States) in Healthy Adults

Tumor

China
Qilu Pharmaceutical Co., Ltd.

Recruiting

A Phase 3 Clinical Study of QLM3004 in Delaying Myopia in Children

Myopia

China
Daewoong Pharmaceutical Co. LTD.

Recruiting

Drug-drug Interactions Between DWC202313 and DWC202314 in Healthy Subjects

Drug Drug Interaction

Korea, Republic of
Qilu Pharmaceutical Co., Ltd.

Not yet recruiting

A Phase 2 Study of QLM3003 Ointment in Participants With Mild or Moderate Atopic Dermatitis

Atopic Dermatitis

China
Daewoong Pharmaceutical Co. LTD.

Recruiting

Evaluate the Efficacy and Safety of DWJ108J

Central Precocious Puberty

Korea, Republic of
Biotech Pharmaceutical Co., Ltd.

Not yet recruiting

Nimotuzumab Combined With Paclitaxel for Recurrent Metastatic Gastric or Esophagogastric Junction Adenocarcinoma (NOTABLE-307)

Gastric or Esophagogastric Junction Adenocarcinoma
Biotech Pharmaceutical Co., Ltd.

Not yet recruiting

Safety and Preliminary Clinical Activity of Itolizumab in ARDS

Acute Respiratory Distress Syndrome
Qilu Pharmaceutical Co., Ltd.

Not yet recruiting

A Study of QL1706 in Combination With Bevacizumab and/or Chemotherapy as First-line Treatment in Patients With Advanced Hepatocellular Carcinoma

Hepatocellular Carcinoma

China
Qilu Pharmaceutical Co., Ltd.

Not yet recruiting

Trial of QLH12016 in Patients With Metastatic Castration Resistant Prostate Cancer

Prostate Cancer

China
Daewoong Pharmaceutical Co. LTD.

Not yet recruiting

Bioequivalence Study for the Safety and the Pharmacokinetics of DWJ1543 in Healthy Adult Volunteers

Healthy Volunteers
Qilu Pharmaceutical Co., Ltd.

Not yet recruiting

Efficacy and Safety of Semaglutide Ingection in Subjects With Type 2 Diabetes

Type 2 Diabetes

China
Qilu Pharmaceutical Co., Ltd.

Recruiting

A Study of QLS32015 in Patients With Recurrent or Refractory Multiple Myeloma

Relapsed or Refractory Multiple Myeloma

China
Daewoong Pharmaceutical Co. LTD.

Recruiting

A Study to Evaluate the Efficacy and Safety of CREZET Tablet

Dyslipidemias

Korea, Republic of
Qilu Pharmaceutical Co., Ltd.

Recruiting

Phase I Study of QLS1103 in Subjects With Advanced Solid Tumors

Advanced Solid Tumor

China
Qilu Pharmaceutical Co., Ltd.

Recruiting

Safety and Efficacy Study of QLF31907 in Advanced Melanoma and Urothelial Carcinoma

Melanoma | Urothelial Carcinoma

China
Boryung Pharmaceutical Co., Ltd

Recruiting

An Observational Study to Analyze the Prescription Pattern of Sugammadex and Its Effectiveness and Safety (SECURE)

Postoperative Complications | Anesthesia | Neuromuscular Blockade

Korea, Republic of
Taiho Pharmaceutical Co., Ltd.

Recruiting

A Study of TAS3731 in Healthy Adults

Healthy Adult Males

Japan

Clinical Trials Sponsored by Intas Pharmaceuticals, Ltd.

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Burkina Faso

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations